Literature DB >> 9266633

Comparative features of hepatitis C virus infection in humans and chimpanzees.

C M Walker1.   

Abstract

Several features of human HCV infection are recapitulated in the chimpanzee model. Most importantly, the frequency of persistent infection is high in both species, and virus replication occurs despite evidence of cellular and humoral immune responses. A key difference is that necroinflammatory lesions in chronically infected chimpanzees are almost always mild, whereas in humans the disease spectrum is very wide, ranging from mild to severe hepatitis and end-stage cirrhosis requiring transplantation. Understanding the basis for both the similarities and differences in persistent hepatitis C in the two species will probably be important for the development of effective prevention and therapy of HCV infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266633     DOI: 10.1007/bf00945027

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  90 in total

1.  High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.

Authors:  J I Esteban; J C López-Talavera; J Genescà; P Madoz; L Viladomiu; E Muñiz; C Martin-Vega; M Rosell; H Allende; X Vidal
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

2.  Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection.

Authors:  S L Tsai; P J Chen; L H Hwang; J H Kao; J H Huang; T H Chang; D S Chen
Journal:  J Hepatol       Date:  1994-09       Impact factor: 25.083

Review 3.  Hepatitis C virus-specific T lymphocyte responses.

Authors:  C M Rice; C M Walker
Journal:  Curr Opin Immunol       Date:  1995-08       Impact factor: 7.486

4.  Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus.

Authors:  N Kato; H Sekiya; Y Ootsuyama; T Nakazawa; M Hijikata; S Ohkoshi; K Shimotohno
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

5.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.

Authors:  M J Koziel; D Dudley; N Afdhal; Q L Choo; M Houghton; R Ralston; B D Walker
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C.

Authors:  A L Erickson; M Houghton; Q L Choo; A J Weiner; R Ralston; E Muchmore; C M Walker
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

Review 7.  Hepatitis C virus: historical perspective and current concepts.

Authors:  R H Purcell
Journal:  FEMS Microbiol Rev       Date:  1994-07       Impact factor: 16.408

8.  Temporal relationships of hepatitis C virus RNA and antibody responses following experimental infection of chimpanzees.

Authors:  M J Beach; E L Meeks; L T Mimms; D Vallari; L DuCharme; J Spelbring; S Taskar; J B Schleicher; K Krawczynski; D W Bradley
Journal:  J Med Virol       Date:  1992-03       Impact factor: 2.327

9.  Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.

Authors:  M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  Patr-A and B, the orthologues of HLA-A and B, present hepatitis C virus epitopes to CD8+ cytotoxic T cells from two chronically infected chimpanzees.

Authors:  H Kowalski; A L Erickson; S Cooper; J D Domena; P Parham; C M Walker
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  25 in total

1.  Loss of Siglec expression on T lymphocytes during human evolution.

Authors:  Dzung H Nguyen; Nancy Hurtado-Ziola; Pascal Gagneux; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

Review 2.  Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees.

Authors:  Babs E Verstrepen; André Boonstra; Gerrit Koopman
Journal:  World J Hepatol       Date:  2015-01-27

3.  Innate immune responses to TLR2 and TLR4 agonists differ between baboons, chimpanzees and humans.

Authors:  J F Brinkworth; E A Pechenkina; J Silver; S M Goyert
Journal:  J Med Primatol       Date:  2012-09-17       Impact factor: 0.667

4.  Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation.

Authors:  Paula C Soto; Lance L Stein; Nancy Hurtado-Ziola; Stephen M Hedrick; Ajit Varki
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

5.  Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies.

Authors:  Judith M Gottwein; Troels K H Scheel; Benoit Callendret; Yi-Ping Li; Heather B Eccleston; Ronald E Engle; Sugantha Govindarajan; William Satterfield; Robert H Purcell; Christopher M Walker; Jens Bukh
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

6.  Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.

Authors:  Michelina Nascimbeni; Eishiro Mizukoshi; Markus Bosmann; Marian E Major; Kathleen Mihalik; Charles M Rice; Stephen M Feinstone; Barbara Rehermann
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.

Authors:  S E Bassett; D L Thomas; K M Brasky; R E Lanford
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response.

Authors:  C Rollier; E Depla; J A R Drexhage; E J Verschoor; B E Verstrepen; A Fatmi; C Brinster; A Fournillier; J A Whelan; M Whelan; D Jacobs; G Maertens; G Inchauspé; J L Heeney
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome.

Authors:  Sergio A Jimenez; Sonsoles Piera-Velazquez
Journal:  Autoimmun Rev       Date:  2013-05-15       Impact factor: 9.754

10.  Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge.

Authors:  Marian E Major; Kathleen Mihalik; Montserrat Puig; Barbara Rehermann; Michelina Nascimbeni; Charles M Rice; Stephen M Feinstone
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.